These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 2833734)

  • 21. Comparative physical dependence studies in rats with flupirtine and opiate receptor stimulating analgesics.
    Nickel B; Aledter A
    Postgrad Med J; 1987; 63 Suppl 3():41-3. PubMed ID: 2833735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abuse potential and physical dependence liability studies with flupirtine maleate in laboratory animals.
    Sofia RD; Diamantis W; Gordon R
    Postgrad Med J; 1987; 63 Suppl 3():35-40. PubMed ID: 3447127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with flupirtine and opioid: studies in rat pain models.
    Goodchild CS; Kolosov A; Tucker AP; Cooke I
    Pain Med; 2008 Oct; 9(7):928-38. PubMed ID: 18950446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
    Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
    Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of noradrenergic descending pain-modulating pathways in the mode of antinociceptive action of flupirtine, a novel non-opioid analgesic.
    Nickel B; Engel J; Szelenyi I
    Agents Actions; 1988 Feb; 23(1-2):112-6. PubMed ID: 3354374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
    Yue CQ; Ye J; Li CL; Li RT; Sun Q
    Pharmacol Biochem Behav; 2007 Apr; 86(4):643-50. PubMed ID: 17379285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat.
    Swedberg MD; Shannon HE; Nickel B; Goldberg SR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1067-74. PubMed ID: 2901483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
    Churiukanov VV
    Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
    Obermeier K; Niebch G; Thiemer K
    Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A long-form alpha-neurotoxin from cobra venom produces potent opioid-independent analgesia.
    Chen ZX; Zhang HL; Gu ZL; Chen BW; Han R; Reid PF; Raymond LN; Qin ZH
    Acta Pharmacol Sin; 2006 Apr; 27(4):402-8. PubMed ID: 16539838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemedolac: a novel and long-acting non-narcotic analgesic.
    Chau TT; Weichman BM
    J Pharmacol Exp Ther; 1989 Mar; 248(3):907-15. PubMed ID: 2703977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
    Björkman R
    Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.